Dr Malinda Itchins BMedSci, MBBS(Hons1), PhD, FRACP, is a thoracic medical oncologist at Royal North Shore Hospital, GenesisCare, and North Shore Private. In 2020 she graduated from University of Sydney in her doctoral studies investigating drug resistance in ALK-rearranged non-small cell lung cancer both preclinically and clinically. Malinda is a Board Director and the Lung Cancer Chair of the Clinical Oncology of Australia (COSA), and Advanced NSCLC Co-Chair for the Thoracic Oncology Group of Australasia (TOGA) Scientific Committee. She is Primary Investigator on multiple lung cancer clinical trials and her research focus to date has been in patterns of care, the real-world experience and drug resistance in oncogene driven lung cancers. She is passionate about the evolution of precision medicine and equity of access to care in thoracic cancers.